KEPPRA 500 mg, film-coated tablet 60 tablets
Brand page: Keppra (levetiracetam) — all forms and strengths in France
Active ingredients: (S)-etiracetam
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet60 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- KEPPRA 500 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-aluminium de 60 comprimé(s)
- Marketing authorisation holder
- UCB PHARMA BELGIQUE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Jan 2001
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68596770CIP73560165CIP133400935601650Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉVÉTIRACÉTAMcomprimé | 500 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
- 60 tablets, parallel import (Mediwin Ldt)Commercialized according to BDPM
- 60 tablets, parallel import (BB Farma)Commercialized according to BDPM
- 60 tablets, parallel import (Inter Trade Pharma)Commercialized according to BDPM
- 60 tablets, parallel import (Pharmalab)Commercialized according to BDPM
- 100 tabletsCommercialized according to BDPM
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.